Posted 2 February 2018 in JOTS Highlights by Melissa E. Dichter, PhD, MSW
Intimate partner violence (IPV) is the term used to refer to violence and abuse in various forms (including psychological, physical, sexual, financial), perpetrated by a current or former intimate partner (including spouse or other romantic or sexual partner; World Health Organization, United Nations Development Programme & United Nations Office on Drugs and Crime, 2014). In the United States, it is estimated that more than one in three women experience rape, physical violence, or stalking from an intimate partner in their lifetimes (Black et al., 2011); prevalence and incident rates vary by measurement tools and constructs measured. IPV is associated with numerous adverse outcomes, including physical injuries, chronic health conditions, trauma-related mental health symptoms, unhealthy substance use, housing instability, and suicidality.
Posted 2 February 2018 in JOTS Highlights by Elizabeth J. Schilpzand, Rowena Conroy, Vicki Anderson, Eva Alisic
Parental responses are thought to be critical to children’s recovery from trauma. Parent and child PTSD often occur together (Morris, Gabert-Quillen, & Delahanty, 2012), parents appear to make important contributions to the treatment of child PTSD (Gutermann et al., 2016), and a range of parenting behaviors are associated with childhood PTSD (Williamson et al., 2017). Despite acknowledgement in the field that parents play an important role in children’s recovery from trauma, we currently have limited understanding about the processes by which parents could influence child outcomes. Improving our understanding of these mechanisms will help us better prevent and treat adverse outcomes for families after a child experiences a traumatic event. In our recent research, we have focused on the role of cognitions.
Posted 2 February 2018 in JOTS Highlights by Archana Varma MD, Michael Moore MD
Topiramate, an anticonvulsant agent, has been studied as a primary and adjunctive treatment for PTSD, yet little is known regarding the efficacy of this treatment approach. The neurochemical basis for PTSD is hypothesized to involve kindling of the limbic nuclei and increased susceptibility to arousal. Anticonvulsants have been investigated as potential augmentation or monotherapy strategies to treat PTSD due to their anxiolytic and anti- kindling effects.